FOXO4-DRI is also known as Proxofim (research designation), FOXO4 D-Retro-Inverso peptide (full descriptive name), Forkhead box O4 (DRI) (gene-derived name), and FOX04-DRI (alternative spelling)
Dopamine system involvement adds another regulatory dimension
Genome Medicine
McCarthy, the Amazon spokesperson, declined to comment on whether Amazon was aware sellers disguised drug listings under research labels
On dosagepeptide.com they are framed research-use-only see the Cagrilintide 5 mg vial research dosage reference, the Cagrilintide 10 mg vial reference, and the cagrilintide weekly dosage chart
This includes reclassifying them as Schedule III controlled substances, thereby rendering their possession and distribution illegal, analogous to anabolic steroids